EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Peptides in breast cancer therapy: From mechanisms to emerging drug delivery and immunotherapy strategies

Elmira Alaei, Farid Hashemi, Najma Farahani, Safa Tahmasebi, Noushin Nabavi, Salman Daneshi, Behnaz Mahmoodieh, Payman Rahimzadeh, Afshin Taheriazam, Mehrdad Hashemi

Pathology - Research and Practice · 2025

DOI: 10.1016/j.prp.2025.155946 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Elmira Alaei und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Breast Neoplasms, Immunotherapy, Drug Delivery Systems, Peptides. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 150 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer therapy can be improved by the application of multifunctional peptides and they have unique features, such as high specificity, minimized toxicity, and the capability to influence diverse processes. The role of peptides in breas cancer therapy is highlighted in the present review, examining their functions as therapeutic agents, diagnostic tools, and drug delivery application. Therapeutic peptides have displayed the ability to regulate key pathways in breast tumor, including HER2, VEGF, and EGFR, providing ideal alternatives to the conventional chemotherapy with reduced adverse effects. Additionally, peptide-based vaccines and immune-modulating peptides have demonstrated the capacity in enhancing anti-cancer immunity. The incorporation of peptides into nanoparticles has improved the delivery of drugs and genes, enhanced anti-cancer efficacy while minimizing side impacts. The progresses in the peptide engineering, including stapled peptides, peptide-drug conjugates, and cell-penetrating peptides, have remarkably increased their therapeutic efficacy and stability, elevating their applications in breast cancer therapy. Peptides can be developed using bioinformatics and high-throughput screening technologies to optimize pharmacokinetics and bioavailability. Despite their promise, peptides demonstrate challenges such as enzymatic degradation, limited stability, and high production costs. These obstacles can be addressed through strategies such as peptide cyclization, the employement of non-natural amino acids, and nanoparticle encapsulation. This review explores these recent advancements and strategies, providing ideal insights into the clinical potential of peptides in breast tumor therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsImmunotherapyDrug Delivery SystemsPeptidesAntineoplastic AgentsHumansFemaleAnimalsNanoparticlesCancer Vaccines

Stichwörter der Autor:innen

Breast tumorDrug deliveryImmunotherapyNanoparticlesPeptides

Substanzen

PeptidesAntineoplastic AgentsCancer Vaccines

Autor:innen und Institutionen

  • School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Comparative Biosciences, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
  • Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Independent Researcher, Victoria, British Columbia V8V 1P7, Canada.
  • Department of Public Health, School of Health, Jiroft University of Medical Sciences, Jiroft, Iran.

Zitieren

APA

Alaei, E., Hashemi, F., Farahani, N., Tahmasebi, S., Nabavi, N., Daneshi, S., Mahmoodieh, B., Rahimzadeh, P., Taheriazam, A., & Hashemi, M. (2025). Peptides in breast cancer therapy: From mechanisms to emerging drug delivery and immunotherapy strategies. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.155946

Vancouver

Alaei E, Hashemi F, Farahani N, Tahmasebi S, Nabavi N, Daneshi S, et al. Peptides in breast cancer therapy: From mechanisms to emerging drug delivery and immunotherapy strategies. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.155946

BibTeX
@article{Alaei2025,
  author = {Alaei, Elmira and Hashemi, Farid and Farahani, Najma and Tahmasebi, Safa and Nabavi, Noushin and Daneshi, Salman and Mahmoodieh, Behnaz and Rahimzadeh, Payman and Taheriazam, Afshin and Hashemi, Mehrdad},
  title = {Peptides in breast cancer therapy: From mechanisms to emerging drug delivery and immunotherapy strategies},
  journal = {Pathology - Research and Practice},
  year = {2025},
  doi = {10.1016/j.prp.2025.155946}
}
Kostenlos starten →